Clinical Trial Update: Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluating sequential oral testosterone undecanoate followed by enzalutamide in men with metastatic castration-resistant prostate cancer has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Enzalutamide (enzalutamide)
• Oral testosterone undecanoate (testosterone undecanoate)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Prostate Cancer, Castration-resistant Prostate Cancer | Phase 2 | Status: COMPLETED